DOCSLIB.ORG

Acute Regulation of Glut1 Function: the Role Of

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Acute Regulation of Glut1 Function: the Role Of ACUTE REGULATION OF GLUT1 FUNCTION: THE ROLE OF DETERGENT-RESISTANT MEMBRANE DOMAINS by DARRELL RUBIN Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Thesis Adviser: Dr. Faramarz Ismail-Beigi Department of Pathology CASE WESTERN RESERVE UNIVERSITY August 2004 Copyright © 2004 by Darrell Casimir Rubin All rights reserved CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ______________________________________________________ candidate for the Ph.D. degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. Dedication To my family and all the people providing inspiration or motivation along the way. Table of Contents Table of Contents …………………………………………………………………. v List of Tables and Figures ………………………………………………………... vii Acknowledgements ………………………………………………………………... ix List of Abbreviations ……………………………………………………………... x Abstract ……………………………………………………………………………. xi Chapter 1 Introduction Members of the Glucose Transporter Family …………………….. 1 Clone 9 cells and the Regulation of Glucose Transport ………….. 6 Protocols for Subcellular Fractionation …………………………... 8 Glucose Transporter Compartmentalization ……………………… 16 The Activation of Glucose Transporters ………………………….. 20 Membrane Microdomains and Glucose Transport Regulation …… 31 Chapter 2 Distribution of Glut1 in Detergent-Resistant Membranes (DRMs) and non-DRM domains: Effect of Treatment with Azide Introduction ……………………………………………………….. 52 Materials and Methods ……………………………………………. 55 Results …………………………………………………………….. 60 Discussion ………………………………………………………… 65 v Chapter 3 Distribution of Glut1 in Clone 9 cells and to Plasma Membrane DRM and non-DRM Domains: Effect of Azide Introduction ……………………………………………………….. 79 Materials and Methods ……………………………………………. 82 Results …………………………………………………………….. 89 Discussion ………………………………………………………… 94 Chapter 4 The Effects of Methyl-β-Cyclodextrin on Glut1 and Glucose Transport Introduction ……………………………………………………….. 117 Materials and Methods ……………………………………………. 120 Results …………………………………………………………….. 123 Discussion ………………………………………………………… 125 Chapter 5 Summary and Future Studies Summary ………………………………………………………….. 140 Future Studies ……………………………………………………... 141 Works Cited ……………………………………………………………………... 145 vi List of Figures and Tables Table 1.1 The glucose transporter family ………………………………... 37 Figure 1.1 Schematics of SLCA2 glucose transporters …………………... 39 Figure 1.2 Dendrogram SLCA2 family glucose transporters ……………... 41 Figure 1.3 Protocols for subcellular fractionation ………………………… 43 Figure 2.1 Low density DRMs in Triton X-100 cell lysate ………………... 69 Figure 2.2 DRMs in cell lysate produced with other detergents …………... 71 Figure 2.3 Low density DRMs in Triton X-100 cell lysate: Azide effect … 73 Table 2.1 The azide effect on glucose transport and Glut1 in the DRMs ... 75 Figure 2.4 Low density DRMs in the plasma membrane: Azide effect …… 77 Figure 3.1 Electron microscopy of preparative gradient fractions …………. 101 Figure 3.2 Protein distribution in Clone 9 cell post-nuclear homogenate …... 103 Table 3.1 Protein distribution in Clone 9 cell post-nuclear homogenate …. 104 Figure 3.3 Glut1 colocalization with other proteins ………………………… 106 Table 3.2 Glut1 colocalization with other proteins ………………………... 107 Figure 3.4 Caveolin-1 in plasma membrane microdomains ………………... 109 Figure 3.5 Glut1 in plasma membrane microdomains: Azide effect ………. 111 Figure 3.6 Glut1 distribution in plasma membrane microdomains …………. 113 Figure 3.7 Glut1 content in plasma membrane microdomains ……………... 115 Table 3.3 Glut1 in plasma membrane microdomains: Azide effect ……… 116 vii Figure 4.1 mβcd blocks azide – induced glucose transport ………………… 130 Table 4.1 Glucose transport by inhibitors of respiration blocked by mβcd ... 131 Figure 4.2 mβcd-treated Clone 9 cells can recover the azide response ……... 133 Figure 4.3 mβcd blocks glucose transport stimulated by ETC inhibition …... 135 Figure 4.4 mβcd decreases Glut1 association with the DRM ………………. 137 Table 4.2 mβcd decreases Glut1 association with the DRM ………………. 139 viii Acknowledgements I thank Dr. Faramarz Ismail – Beigi for his patient guidance and his generous dedication to my education and progress. The other members of my committee Dr. George Dubyak, Dr. Alan Levine, Dr. Sanjay Pimplikar, and Dr. Alan Tartakoff contributed their time, expertise, and guidance for which I am grateful. The department of Pathology, led first by Dr. Micheal Lamm and succeeded by Dr. George Perry, has been a great place for my training. I have had the pleasure of learning from two laboratories during the course of my graduate education and both provided numerous experiences which have helped my development as a scientist tremendously. I also thank my immediate family for their unwavering support during this time in my career as a student. Of my friends, I especially thank Michael Payne for his support. Finally, I acknowledge the staff and director of the Medical Scientist Training Program, especially former program coordinator Felicite Katz and director emeritus Dr. John Nilson, for their support. ix List of Abbreviations Homog homogenization SDH succinic dehydrogenase M-J McKeel and Jarret DRM detergent – resistant membrane PM plasma membrane LDM low density membrane HDM high density membrane ETC electron transport chain 3H tritium x ACUTE REGULATION OF GLUT1 FUNCTION: THE ROLE OF DETERGENT-RESISTANT MEMBRANE DOMAINS Abstract by DARRELL RUBIN Identifying which processes and proteins control glucose transport could provide important clues to understanding and treating a number of clinical entities including diabetes and some cancers. Glucose transport across the plasma membrane occurs by either sodium-dependent or independent glucose transporters. In order to study the mechanisms which control acute changes in glucose transport by sodium-independent glucose transporters, we use the non-transformed rat liver – derived Clone 9 cell line. These cells respond to the acute inhibition of oxidative phosphorylation by azide with a 4-6 fold stimulation of glucose transport and a 1.8 fold increase in the amount of glucose transporter 1 (Glut1) in the plasma membrane. In Clone 9 cells under basal conditions, ~38 % of Glut1 in the post-nuclear lysate is localized to the detergent-resistant membrane (DRM) microdomains. Acute exposure to azide decreased this figure by ~40 %. In order to examine the effects of azide on Glut1 localization to the plasma membrane of the Clone 9 cell, we performed subcellular fractionation of the post-nuclear homogenates. Approximately 30 % of the Glut1 in the post-nuclear homogenate was recovered in the plasma membrane (PM) compartment and 50 % of this PM Glut1 localized to the DRM fraction. Acute inhibition of oxidative phosphorylation with azide xi resulted in a 1.6-fold increase in the total abundance of Glut1 in the PM and was associated with a 2.9 fold increase in the abundance of Glut1 in the non-DRM fraction but no significant change in the content of Glut1 in the DRM fraction. We conclude that in the Clone 9 cell Glut1 localizes to detergent-resistant membrane microdomains in the plasma membrane. Moreover, in these cells the azide – induced increase in glucose transport is associated with an increase of Glut1 abundance in the non – DRM fraction of the plasma membrane and a decrease of Glut1 association with the DRM fraction of a membrane compartment other than the plasma membrane. These findings indicate that the distribution of Glut1 to the DRM and non-DRM domains of the cellular membrane compartments contribute, in part, to the mechanisms of glucose transport regulation in response to the acute inhibition of oxidative phosphorylation. xii Chapter 1 Introduction Abnormal responses to increased blood glucose are an important clinical signal suggesting the patient may be at risk for or already suffer from pathological processes leading to diabetes (Bjornholt et al., 2001). It has also been suggested that the prognosis of patients with certain tumors correlates with the expression of Glut1 (Kurokawa et al., 2004; Vordermark et al., 2003). Identifying which processes and proteins control glucose transport may facilitate the development of improved therapies for managing the course of disease in these patients. Members of the Glucose Transporter Family There are many members of the facilitative glucose transporter family (gene name Solute Carrier (SLCA) 2A) designated Glut1 – 14 including the proton/myoinositol co- transporter (HMIT) (Table 1.1) (Joost et al., 2001; Wood et al., 2003b). These integral membrane proteins have 12 transmembrane domains and a glycosylation site present in one extracellular loop. The most recent additions to the Glut family were identified based on the greater than 28% identity of their primary sequences with that of Glut1 and the presence of the so-called “sugar transporter signature” sequences (Figure 1.1) which are conserved among Glut1 – 5 (Joost et al., 2001). The family was subdivided into three classes based on sequence identity (Figure 1.2). The following short discussion regarding the Glut family summarizes the
Load more

Recommended publications
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
    [Show full text]
  • (Glut1ds): Methylxanthines Potentiate GLUT1 Haploinsufficiency in Vitro
    0031-3998/01/5002-0254 PEDIATRIC RESEARCH Vol. 50, No. 2, 2001 Copyright © 2001 International Pediatric Research Foundation, Inc. Printed in U.S.A. Glucose Transporter Type 1 Deficiency Syndrome (Glut1DS): Methylxanthines Potentiate GLUT1 Haploinsufficiency In Vitro YUAN-YUAN HO, HONG YANG, JÖRG KLEPPER, JORGE FISCHBARG, DONG WANG, AND DARRYL C. DE VIVO Department of Neurology, Columbia University, New York, New York 10032, U.S.A. [Y.Y.H., H.Y., D.W., D.C.D.]; Department of Pediatrics, University of Essen, Essen, Germany 45122 [J.K.]; and Departments of Physiology and Cellular Biophysics, and Ophthalmology, Columbia University, New York, New York 10032, U.S.A. [J.F.] ABSTRACT Methylxanthines such as caffeine and theophylline are known substrate for Glut1. The combined effects of caffeine (3 mM) and to inhibit glucose transport. We have studied such inhibition in phenobarbital (10 mM) on glucose transport, as determined in the glucose transporter type 1 deficiency syndrome (Glut1DS) by patient 15 and the maternal control, show no additive or syner- erythrocyte glucose transport assays. Data from four patients gistic inhibition. These data indicate that caffeine and phenobar- with individual mutations in the GLUT1 gene are discussed: bital have similar Glut1 inhibitory properties in these two sub- patient 1 (hemizygosity), 3 (S66F), 15 (368Ins23), and 17 jects. Our study suggests that Glut1DS patients may have a (R333W). Zero-trans influx of 14C-labeled 3-O-methyl glucose reduced safety margin for methylxanthines. Consumption of (3-OMG) into erythrocytes of patients is reduced (patient 1, 51%; methylxanthine-containing products may aggravate the neuro- 3, 45%; 15, 31%; 17, 52%) compared with maternal controls.
    [Show full text]
  • Regulation of Myocardial Glucose Transporters GLUT1 and GLUT4 in Chronically Anemic Fetal Lambs
    0031-3998/05/5804-0713 PEDIATRIC RESEARCH Vol. 58, No. 4, 2005 Copyright © 2005 International Pediatric Research Foundation, Inc. Printed in U.S.A. Regulation of Myocardial Glucose Transporters GLUT1 and GLUT4 in Chronically Anemic Fetal Lambs J. CARTER RALPHE, PETER N. NAU, CHRISTOPHER E. MASCIO, JEFFREY L. SEGAR, AND THOMAS D. SCHOLZ Department of Pediatrics [J.C.R., P.N.N., J.L.S., T.D.S.], Department of Surgery [C.E.M.], University of Iowa, Iowa City, Iowa 52242 ABSTRACT Little is known about the chronic adaptations that take place steady state, GLUT4 protein localized to the sarcolemma mem- in the fetal heart to allow for increased substrate delivery in brane. These findings suggest that the glucose transporters are response to chronic stress. Because glucose is an important fuel post-transcriptionally regulated in myocardium of chronically for the fetal cardiomyocytes, we hypothesized that myocardial anemic fetal sheep with changes that mimic normal postnatal glucose transporters 1 and 4 (GLUT1 and GLUT4, respectively) development. Unlike the postnatal heart, localization of GLUT4 are up-regulated in the fetal sheep heart that is chronically to the cell membrane suggests the importance of GLUT4 in basal stressed by anemia. Fetal sheep at 128 d gestation underwent glucose uptake in the stressed fetal heart. (Pediatr Res 58: daily isovolumic hemorrhage and determination of myocardial 713–718, 2005) blood flow, oxygen consumption, and substrate utilization. At the endof3or7dofanemia, myocardial levels of GLUT1 and Abbreviations GLUT4 mRNA and protein were measured and subcellular ERK, extracellular-regulated kinase localization was determined. Despite stable heart rate and blood GLUT1(4), glucose transporter 1 (4) pressure, anemia caused a nearly 4-fold increase in right and left HIF-1␣, hypoxia-inducible factor 1␣ ventricular (RV and LV) free wall blood flow.
    [Show full text]
  • Is Retinal Metabolic Dysfunction at the Center of the Pathogenesis of Age-Related Macular Degeneration?
    International Journal of Molecular Sciences Review Is Retinal Metabolic Dysfunction at the Center of the Pathogenesis of Age-related Macular Degeneration? Thierry Léveillard 1,*, Nancy J. Philp 2 and Florian Sennlaub 3 1 . Department of Genetics, Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, France 2 . Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA; [email protected] 3 . Department of Therapeutics, Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, France; fl[email protected] * Correspondence: [email protected]; Tel.: +33-1-5346-2548 Received: 21 December 2018; Accepted: 5 February 2019; Published: 11 February 2019 Abstract: The retinal pigment epithelium (RPE) forms the outer blood–retina barrier and facilitates the transepithelial transport of glucose into the outer retina via GLUT1. Glucose is metabolized in photoreceptors via the tricarboxylic acid cycle (TCA) and oxidative phosphorylation (OXPHOS) but also by aerobic glycolysis to generate glycerol for the synthesis of phospholipids for the renewal of their outer segments. Aerobic glycolysis in the photoreceptors also leads to a high rate of production of lactate which is transported out of the subretinal space to the choroidal circulation by the RPE. Lactate taken up by the RPE is converted to pyruvate and metabolized via OXPHOS. Excess lactate in the RPE is transported across the basolateral membrane to the choroid. The uptake of glucose by cone photoreceptor cells is enhanced by rod-derived cone viability factor (RdCVF) secreted by rods and by insulin signaling. Together, the three cells act as symbiotes: the RPE supplies the glucose from the choroidal circulation to the photoreceptors, the rods help the cones, and both produce lactate to feed the RPE.
    [Show full text]
  • Mechanistic Insights Into GLUT1 Activation and Clustering Revealed by Super-Resolution Imaging
    Mechanistic insights into GLUT1 activation and clustering revealed by super-resolution imaging Qiuyan Yana,b, Yanting Lub,c, Lulu Zhoua,b, Junling Chena, Haijiao Xua, Mingjun Caia, Yan Shia, Junguang Jianga, Wenyong Xiongc,1, Jing Gaoa,1, and Hongda Wanga,d,1 aState Key Laboratory of Electroanalytical Chemistry, Research Center of Biomembranomics, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022 Jilin, P. R. China; bSchool of Chemistry and Chemical Engineering, University of Chinese Academy of Sciences, 100049 Beijing, P. R. China; cState Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201 Yunnan, P. R. China; and dLaboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Aoshanwei, Jimo, Qingdao, 266237 Shandong, P. R. China Edited by Nieng Yan, Princeton University, Princeton, NJ, and accepted by Editorial Board Member Alan R. Fersht May 24, 2018 (received for review March 9, 2018) The glucose transporter GLUT1, a plasma membrane protein that super-resolution fluorescence microscopy, which breaks the dif- mediates glucose homeostasis in mammalian cells, is responsible fraction barrier and achieves a lateral resolution in the tens of for constitutive uptake of glucose into many tissues and organs. nanometers (17), has provided a particularly suitable tool to solve Many studies have focused on its vital physiological functions and these problems. Meanwhile, it has been proven that multiprotein close relationship with diseases. However, the molecular mecha- assemblies are dependent on cholesterol environment, and their nisms of its activation and transport are not clear, and its detailed separation and anchoring are related to the actin cytoskeleton (18, distribution pattern on cell membranes also remains unknown.
    [Show full text]
  • NDUFAB1 Protects Heart by Coordinating Mitochondrial Respiratory Complex
    bioRxiv preprint doi: https://doi.org/10.1101/302281; this version posted April 16, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. NDUFAB1 Protects Heart by Coordinating Mitochondrial Respiratory Complex and Supercomplex Assembly Running title: Hou et al. Cardiac Protection by NDUFAB1 Tingting Hou 1; Rufeng Zhang 1; Chongshu Jian 1; Wanqiu Ding 1; Yanru Wang 1; Qi Ma 1; Xinli Hu 1; Heping Cheng 1,†; Xianhua Wang 1,† 1State Key Laboratory of Membrane Biology, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking-Tsinghua Center for Life Sciences, Institute of Molecular Medicine, Peking University, China. † Corresponding author. Xianhua Wang Tel: 86-10-62754605 Email: [email protected] Heping Cheng Tel: 86-10-62765957 Email: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/302281; this version posted April 16, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The impairment of mitochondrial bioenergetics, often coupled with exaggerated reactive oxygen species (ROS) production, is emerging as a common mechanism in diseases of organs with a high demand for energy, such as the heart. Building a more robust cellular powerhouse holds promise for protecting these organs in stressful conditions. Here, we demonstrate that NDUFAB1 (NADH:ubiquinone oxidoreductase subunit AB1), acts as a powerful cardio-protector by enhancing mitochondrial energy biogenesis. In particular, NDUFAB1 coordinates the assembly of respiratory complexes I, II, and III and supercomplexes, conferring greater capacity and efficiency of mitochondrial energy metabolism.
    [Show full text]
  • Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level
    International Journal of Molecular Sciences Review Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level Sweilem B. Al Rihani 1 , Lucy I. Darakjian 1, Malavika Deodhar 1 , Pamela Dow 1 , Jacques Turgeon 1,2 and Veronique Michaud 1,2,* 1 Tabula Rasa HealthCare, Precision Pharmacotherapy Research and Development Institute, Orlando, FL 32827, USA; [email protected] (S.B.A.R.); [email protected] (L.I.D.); [email protected] (M.D.); [email protected] (P.D.); [email protected] (J.T.) 2 Faculty of Pharmacy, Université de Montréal, Montreal, QC H3C 3J7, Canada * Correspondence: [email protected]; Tel.: +1-856-938-8697 Abstract: The blood–brain barrier (BBB) is a highly selective and restrictive semipermeable network of cells and blood vessel constituents. All components of the neurovascular unit give to the BBB its crucial and protective function, i.e., to regulate homeostasis in the central nervous system (CNS) by removing substances from the endothelial compartment and supplying the brain with nutrients and other endogenous compounds. Many transporters have been identified that play a role in maintaining BBB integrity and homeostasis. As such, the restrictive nature of the BBB provides an obstacle for drug delivery to the CNS. Nevertheless, according to their physicochemical or pharmacological properties, drugs may reach the CNS by passive diffusion or be subjected to putative influx and/or efflux through BBB membrane transporters, allowing or limiting their distribution to the CNS. Drug transporters functionally expressed on various compartments of the BBB involve numerous proteins from either the ATP-binding cassette (ABC) or the solute carrier (SLC) superfamilies.
    [Show full text]
  • Crystal Structure of a Glucose/H Symporter and Its Mechanism of Action
    + Crystal structure of a glucose/H symporter and its mechanism of action Cristina V. Iancua, Jamillah Zamoonb, Sang Bum Wooa, Alexander Aleshinc, and Jun-yong Choea,1 aDepartment of Biochemistry and Molecular Biology, Rosalind Franklin University of Medicine and Science, The Chicago Medical School, North Chicago,IL 60064; bDepartment of Biological Sciences, Faculty of Science, Kuwait University, Kuwait City 13060, Kuwait; and cDepartment of Infectious Diseases, Sanford Burnham Medical Research Institute, La Jolla, CA 92037 Edited* by H. Ronald Kaback, University of California, Los Angeles, CA, and approved September 26, 2013 (received for review June 25, 2013) + Glucose transporters are required to bring glucose into cells, of a Staphylococcus epidermidis glucose/H symporter (GlcPSe) where it is an essential energy source and precursor in protein by single anomalous dispersion methods. GlcPSe shares high se- and lipid synthesis. These transporters are involved in important quence identity (27–34%) and homology (49–58%) with the hu- common diseases such as cancer and diabetes. Here, we report the man GLUTs (Table S1), is highly specific for glucose, and is + crystal structure of the Staphylococcus epidermidis glucose/H sym- inhibited by the well-characterized inhibitors of human GLUTs porter in an inward-facing conformation at 3.2-Å resolution. The phloretin, cytochalasin B, and forskolin. In contrast to GlcP , + Se Staphylococcus epidermidis glucose/H symporter is homologous XylE transports xylose but not glucose, which is an inhibitor, and is to human glucose transporters, is very specific and has high avidity impervious to inhibition by cytochalasin B (13, 24). On the basis of for glucose, and is inhibited by the human glucose transport inhib- the GlcPSe structure and functional studies of wild-type and mu- itors cytochalasin B, phloretin, and forskolin.
    [Show full text]
  • Downloaded from the App Store and Nucleobase, Nucleotide and Nucleic Acid Metabolism 7 Google Play
    Hoytema van Konijnenburg et al. Orphanet J Rare Dis (2021) 16:170 https://doi.org/10.1186/s13023-021-01727-2 REVIEW Open Access Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app Eva M. M. Hoytema van Konijnenburg1†, Saskia B. Wortmann2,3,4†, Marina J. Koelewijn2, Laura A. Tseng1,4, Roderick Houben6, Sylvia Stöckler‑Ipsiroglu5, Carlos R. Ferreira7 and Clara D. M. van Karnebeek1,2,4,8* Abstract Background: The Treatable ID App was created in 2012 as digital tool to improve early recognition and intervention for treatable inherited metabolic disorders (IMDs) presenting with global developmental delay and intellectual disabil‑ ity (collectively ‘treatable IDs’). Our aim is to update the 2012 review on treatable IDs and App to capture the advances made in the identifcation of new IMDs along with increased pathophysiological insights catalyzing therapeutic development and implementation. Methods: Two independent reviewers queried PubMed, OMIM and Orphanet databases to reassess all previously included disorders and therapies and to identify all reports on Treatable IDs published between 2012 and 2021. These were included if listed in the International Classifcation of IMDs (ICIMD) and presenting with ID as a major feature, and if published evidence for a therapeutic intervention improving ID primary and/or secondary outcomes is avail‑ able. Data on clinical symptoms, diagnostic testing, treatment strategies, efects on outcomes, and evidence levels were extracted and evaluated by the reviewers and external experts. The generated knowledge was translated into a diagnostic algorithm and updated version of the App with novel features. Results: Our review identifed 116 treatable IDs (139 genes), of which 44 newly identifed, belonging to 17 ICIMD categories.
    [Show full text]
  • Frontiersin.Org 1 April 2015 | Volume 9 | Article 123 Saunders Et Al
    ORIGINAL RESEARCH published: 28 April 2015 doi: 10.3389/fnins.2015.00123 Influx mechanisms in the embryonic and adult rat choroid plexus: a transcriptome study Norman R. Saunders 1*, Katarzyna M. Dziegielewska 1, Kjeld Møllgård 2, Mark D. Habgood 1, Matthew J. Wakefield 3, Helen Lindsay 4, Nathalie Stratzielle 5, Jean-Francois Ghersi-Egea 5 and Shane A. Liddelow 1, 6 1 Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC, Australia, 2 Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark, 3 Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, 4 Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland, 5 Lyon Neuroscience Research Center, INSERM U1028, Centre National de la Recherche Scientifique UMR5292, Université Lyon 1, Lyon, France, 6 Department of Neurobiology, Stanford University, Stanford, CA, USA The transcriptome of embryonic and adult rat lateral ventricular choroid plexus, using a combination of RNA-Sequencing and microarray data, was analyzed by functional groups of influx transporters, particularly solute carrier (SLC) transporters. RNA-Seq Edited by: Joana A. Palha, was performed at embryonic day (E) 15 and adult with additional data obtained at University of Minho, Portugal intermediate ages from microarray analysis. The largest represented functional group Reviewed by: in the embryo was amino acid transporters (twelve) with expression levels 2–98 times Fernanda Marques, University of Minho, Portugal greater than in the adult. In contrast, in the adult only six amino acid transporters Hanspeter Herzel, were up-regulated compared to the embryo and at more modest enrichment levels Humboldt University, Germany (<5-fold enrichment above E15).
    [Show full text]
  • Hereditary Xerocytosis Revisited
    SOLVING CLINICAL PROBLEMS IN BLOOD DISEASES AJH AJH Educational Material A physician or group of physicians considers presentation and evolution of a real clinical case, reacting to clinical information and data (boldface type). This is followed by a discussion/commentary Hereditary xerocytosis revisited Natasha M. Archer,1,2 Boris E. Shmukler,3,4 Immacolata Andolfo,5,6 David H. Vandorpe,3,4 Radhakrishnan Gnanasambandam,7 John M. Higgins,8,9 Alicia Rivera,10,11 Mark D. Fleming,11 Frederick Sachs,7 Philip A. Gottlieb,7 Achille Iolascon,5,6 Carlo Brugnara,10,11 Seth L. Alper,3,4,12* and David G. Nathan1,2,13* A 21-year-old male student presented in 1980 as an Olympic ath- corpuscular hemoglobin (MCH), increased osmotic fragility, and mis- lete with a 12-year history of jaundice, pallor, and darkened urine sense mutations in the red cell membrane gene products SLC4A1/ induced by the atraumatic exercise of swimming [1]. Physical AE1, SLC2A1/GLUT1, and RHAG. HX, sometimes referred to as examination at that time was remarkable only for moderate scleral dehydrated stomatocytosis (DHSt), is caused by missense mutations icterus without hepatosplenomegaly. Hematological examination in the ATP binding cassette transporter ABCB6 [4] and in the red revealed moderate macrocytosis (mean corpuscular volume (MCV) cell membrane mechanosensitive cation channel, PIEZO1 [5–7]. Fam- 102 fL) without anemia (Hct 50%, Hb 17 g/dL, 9% reticulocytes). ilial pseudohyperkalemia, a related benign condition, is characterized The peripheral blood smear showed occasional target cells. Red cell by temperature-dependent loss of erythrocyte K, and is an incom- osmotic fragility was decreased.
    [Show full text]
  • A Comprehensive Review of Our Current Understanding of Red Blood Cell (RBC) Glycoproteins
    membranes Review A Comprehensive Review of Our Current Understanding of Red Blood Cell (RBC) Glycoproteins Takahiko Aoki Laboratory of Quality in Marine Products, Graduate School of Bioresources, Mie University, 1577 Kurima Machiya-cho, Mie, Tsu 514-8507, Japan; [email protected]; Tel.: +81-59-231-9569; Fax: +81-59-231-9557 Received: 18 August 2017; Accepted: 24 September 2017; Published: 29 September 2017 Abstract: Human red blood cells (RBC), which are the cells most commonly used in the study of biological membranes, have some glycoproteins in their cell membrane. These membrane proteins are band 3 and glycophorins A–D, and some substoichiometric glycoproteins (e.g., CD44, CD47, Lu, Kell, Duffy). The oligosaccharide that band 3 contains has one N-linked oligosaccharide, and glycophorins possess mostly O-linked oligosaccharides. The end of the O-linked oligosaccharide is linked to sialic acid. In humans, this sialic acid is N-acetylneuraminic acid (NeuAc). Another sialic acid, N-glycolylneuraminic acid (NeuGc) is present in red blood cells of non-human origin. While the biological function of band 3 is well known as an anion exchanger, it has been suggested that the oligosaccharide of band 3 does not affect the anion transport function. Although band 3 has been studied in detail, the physiological functions of glycophorins remain unclear. This review mainly describes the sialo-oligosaccharide structures of band 3 and glycophorins, followed by a discussion of the physiological functions that have been reported in the literature to date. Moreover, other glycoproteins in red blood cell membranes of non-human origin are described, and the physiological function of glycophorin in carp red blood cell membranes is discussed with respect to its bacteriostatic activity.
    [Show full text]